Stock ALZN ALZAMEND NEURO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Alzamend Neuro, Inc.

Equities

ALZN

US02262M4078

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.7 USD -1.30% Intraday chart for Alzamend Neuro, Inc. +1.30% -21.35%
Mar. 25 Alzamend Neuro, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 CI
Jan. 31 Alzamend Neuro, Inc. announced that it expects to receive $6 million in funding from Ault Lending, LLC CI

Evolution of the average Target Price on Alzamend Neuro, Inc.

Price target over the last 5 years

History of analyst recommendation changes

024a9.hKXwZ0MlIyx1xOVcQBweGUn_9IaDgXRYUaWw7wmMlSw.1dWiPSJ2ekQDvqk6AWhILDCov-3XzRA0E9_hrGbc5GXq87s9ExwOARGL3Q~3871173b4125b27110f7188e7276e1ea

Analyst Recommendations on Alzamend Neuro, Inc.

Maxim Initiates Alzamend Neuro at Buy With $1.50 Price Target MT
Ascendiant Capital Adjusts Price Target on Alzamend Neuro to $8.25 From $8, Maintains Buy Rating MT
ALZAMEND NEURO : Ascendiant Capital Initiates Alzamend Neuro at Buy Rating With $8 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.7 USD
Average target price
21 USD
Spread / Average Target
+2,900.00%
High Price Target
21 USD
Spread / Highest target
+2,900.00%
Low Price Target
21 USD
Spread / Lowest Target
+2,900.00%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Alzamend Neuro, Inc.

Maxim
Ascendiant Capital

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ALZN Stock
  4. Consensus Alzamend Neuro, Inc.